Buchumschlag

Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia: circumvention of thymidylate synthase inhibition

Purpose: In about 25% of patients suffering from acute lymphoblastic leukemia (ALL) treatment failures occur that are most likely due to development of resistance to methotrexate (MTX). Blasts from patients with ALL were evaluated for MTX uptake, formation of long-chain MTX polyglutamates (MTX-Glu5+...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weigand, Martina (VerfasserIn) , Frei, Eva (VerfasserIn) , Graf, N. (VerfasserIn) , Buchholz, B. (VerfasserIn) , Wolfrom, C. (VerfasserIn) , Breuer, Andrea (VerfasserIn) , Wießler, Manfred (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1999
In: Journal of cancer research and clinical oncology
Year: 1999, Jahrgang: 125, Heft: 8, Pages: 513-519
ISSN:1432-1335
DOI:10.1007/s004320050310
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s004320050310
Verlag, Volltext: https://doi.org/10.1007/s004320050310
Volltext
Verfasserangaben:M. Weigand, E. Frei, N. Graf, B. Buchholz, C. Wolfrom, A. Breuer, M. Wiessler

MARC

LEADER 00000caa a2200000 c 4500
001 1586754300
003 DE-627
005 20220815094946.0
007 cr uuu---uuuuu
008 190130s1999 xx |||||o 00| ||eng c
024 7 |a 10.1007/s004320050310  |2 doi 
035 |a (DE-627)1586754300 
035 |a (DE-576)516754300 
035 |a (DE-599)BSZ516754300 
035 |a (OCoLC)1341034825 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Weigand, Martina  |d 1961-  |e VerfasserIn  |0 (DE-588)118093363  |0 (DE-627)694663220  |0 (DE-576)291712274  |4 aut 
245 1 0 |a Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia  |b circumvention of thymidylate synthase inhibition  |c M. Weigand, E. Frei, N. Graf, B. Buchholz, C. Wolfrom, A. Breuer, M. Wiessler 
264 1 |c 1999 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.01.2019 
520 |a Purpose: In about 25% of patients suffering from acute lymphoblastic leukemia (ALL) treatment failures occur that are most likely due to development of resistance to methotrexate (MTX). Blasts from patients with ALL were evaluated for MTX uptake, formation of long-chain MTX polyglutamates (MTX-Glu5+6), cytotoxicity and thymidylate synthase inhibition by MTX and compared to blasts from patients with acute myelogenous leukemia (AML). Methods: Radioactively labeled MTX-Glu n were analyzed by means of HPLC. Thymidylate synthase activity was measured by a tritium-release assay. Cytotoxicity was determined by trypan blue exclusion. Results: In most ALL blasts (n = 9) large amounts of MTX-Glu5+6 (1.06-7.03 pmol/107cells) and high cytotoxicity (43.5%-92.7%) were found, while in others small amounts of MTX-Glu5+6 (0.0-0.39 pmol/107cells) caused only weak cytotoxicity (6.0%-27.9%) (n = 5, 2 relapsed patients). Resistance to MTX in blasts from AML patients (n = 5) was also caused by reduced synthesis of MTX-Glu5+6 (0.0-0.42 pmol/107cells). In contrast, some ALL blasts (n = 7, 4 relapsed patients) were able to survive MTX treatment despite large amounts of MTX-Glu5+6 (1.5-5.05 pmol/107cells) and extensive thymidylate synthase inhibition. Conclusions: Since the majority of ALL patients were examined at first diagnosis, an inherent mechanism of resistance seems most likely. We propose a mechanism based on the switch of thymidylate synthesis to the salvage pathway. 
650 4 |a Key words Acute lymphoblastic leukemia 
650 4 |a Methotrexate polyglutamates 
650 4 |a Relapse 
650 4 |a Salvage pathway 
650 4 |a Thymidylate synthase 
700 1 |a Frei, Eva  |d 1950-  |e VerfasserIn  |0 (DE-588)112546450X  |0 (DE-627)880025433  |0 (DE-576)483423068  |4 aut 
700 1 |a Graf, N.  |e VerfasserIn  |4 aut 
700 1 |a Buchholz, B.  |e VerfasserIn  |4 aut 
700 1 |a Wolfrom, C.  |e VerfasserIn  |4 aut 
700 1 |a Breuer, Andrea  |e VerfasserIn  |0 (DE-588)1161560505  |0 (DE-627)102484448X  |0 (DE-576)506731545  |4 aut 
700 1 |a Wießler, Manfred  |e VerfasserIn  |0 (DE-588)117668387X  |0 (DE-627)1047653249  |0 (DE-576)51675419X  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cancer research and clinical oncology  |d Berlin : Springer, 1979  |g 125(1999), 8, Seite 513-519  |h Online-Ressource  |w (DE-627)253769515  |w (DE-600)1459285-X  |w (DE-576)072578319  |x 1432-1335  |7 nnas  |a Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia circumvention of thymidylate synthase inhibition 
773 1 8 |g volume:125  |g year:1999  |g number:8  |g pages:513-519  |g extent:7  |a Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia circumvention of thymidylate synthase inhibition 
856 4 0 |u http://dx.doi.org/10.1007/s004320050310  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1007/s004320050310  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190130 
993 |a Article 
994 |a 1999 
998 |g 117668387X  |a Wießler, Manfred  |m 117668387X:Wießler, Manfred  |d 140000  |e 140000PW117668387X  |k 0/140000/  |p 7  |y j 
998 |g 1161560505  |a Breuer, Andrea  |m 1161560505:Breuer, Andrea  |d 50000  |e 50000PB1161560505  |k 0/50000/  |p 6 
998 |g 112546450X  |a Frei, Eva  |m 112546450X:Frei, Eva  |d 140000  |e 140000PF112546450X  |k 0/140000/  |p 2 
998 |g 118093363  |a Weigand, Martina  |m 118093363:Weigand, Martina  |d 50000  |e 50000PW118093363  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1586754300  |e 3050669829 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 30.01.2019"],"language":["eng"],"recId":"1586754300","title":[{"title_sort":"Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia","title":"Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia","subtitle":"circumvention of thymidylate synthase inhibition"}],"person":[{"given":"Martina","family":"Weigand","role":"aut","roleDisplay":"VerfasserIn","display":"Weigand, Martina"},{"role":"aut","display":"Frei, Eva","roleDisplay":"VerfasserIn","given":"Eva","family":"Frei"},{"roleDisplay":"VerfasserIn","display":"Graf, N.","role":"aut","family":"Graf","given":"N."},{"roleDisplay":"VerfasserIn","display":"Buchholz, B.","role":"aut","family":"Buchholz","given":"B."},{"roleDisplay":"VerfasserIn","display":"Wolfrom, C.","role":"aut","family":"Wolfrom","given":"C."},{"given":"Andrea","family":"Breuer","role":"aut","roleDisplay":"VerfasserIn","display":"Breuer, Andrea"},{"roleDisplay":"VerfasserIn","display":"Wießler, Manfred","role":"aut","family":"Wießler","given":"Manfred"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["253769515"],"zdb":["1459285-X"],"issn":["1432-1335"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1979","publisher":"Springer","dateIssuedDisp":"1979-"}],"part":{"issue":"8","pages":"513-519","year":"1999","extent":"7","text":"125(1999), 8, Seite 513-519","volume":"125"},"titleAlt":[{"title":"Cancer research and clinical oncology"}],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"language":["eng","ger"],"recId":"253769515","disp":"Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia circumvention of thymidylate synthase inhibitionJournal of cancer research and clinical oncology","note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"official organ of the Deutsche Krebsgesellschaft","title":"Journal of cancer research and clinical oncology","title_sort":"Journal of cancer research and clinical oncology"}]}],"origin":[{"dateIssuedDisp":"1999","dateIssuedKey":"1999"}],"id":{"eki":["1586754300"],"doi":["10.1007/s004320050310"]},"name":{"displayForm":["M. Weigand, E. Frei, N. Graf, B. Buchholz, C. Wolfrom, A. Breuer, M. Wiessler"]}} 
SRT |a WEIGANDMARMECHANISMS1999 

Ähnliche Einträge